Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ABL001
ABL001
Novartis’ ABL001 meets primary endpoint of phase 3 chronic myeloid leukemia study
Pharmaceutical Business Review
Thu, 08/27/20 - 11:01 am
Novartis
asciminib
ABL001
clinical trials
chronic myeloid leukemia